Skip to main content
Fig. 1 | BMC Bioinformatics

Fig. 1

From: Comprehensive analysis of KLF2 as a prognostic biomarker associated with fibrosis and immune infiltration in advanced hepatocellular carcinoma

Fig. 1

The expression distribution and prognostic survival value of KLF2 in tumor tissues and normal tissues of TCGA-LIHC and ICGC-LIRI. A The distribution of KLF2 expression across different types of tumor and normal tissues. B The level of KLF2 expression was significantly lower in tumor tissue in ICGC-LIRI (G1: normal liver tissue; G2: primary tumor tissue). C–F Kaplan–Meier survival analysis showed patients with higher KLF2 expression had a significantly better overall survival (OS), progression free survival (PFS), disease free survival (DFS) and disease specific survival (DSS) from TCGA-LIHC. G Kaplan–Meier survival analysis of KLF2 from ICGC-LIRI dataset. *P < 0.05, **P < 0.01, ***P < 0.001

Back to article page

BMC Bioinformatics

ISSN: 1471-2105

Contact us